189 related articles for article (PubMed ID: 10441463)
1. Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy.
Repetto S; Bado M; Broda P; Lucania G; Masetti E; Sotgia F; Carbone I; Pavan A; Bonilla E; Cordone G; Lisanti MP; Minetti C
Biochem Biophys Res Commun; 1999 Aug; 261(3):547-50. PubMed ID: 10441463
[TBL] [Abstract][Full Text] [Related]
2. Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency.
Minetti C; Bado M; Broda P; Sotgia F; Bruno C; Galbiati F; Volonte D; Lucania G; Pavan A; Bonilla E; Lisanti MP; Cordone G
Am J Pathol; 2002 Jan; 160(1):265-70. PubMed ID: 11786420
[TBL] [Abstract][Full Text] [Related]
3. Caveolae and caveolin-3 in muscular dystrophy.
Galbiati F; Razani B; Lisanti MP
Trends Mol Med; 2001 Oct; 7(10):435-41. PubMed ID: 11597517
[TBL] [Abstract][Full Text] [Related]
4. Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C.
Volonte D; Peoples AJ; Galbiati F
Mol Biol Cell; 2003 Oct; 14(10):4075-88. PubMed ID: 14517320
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy.
Minetti C; Sotgia F; Bruno C; Scartezzini P; Broda P; Bado M; Masetti E; Mazzocco M; Egeo A; Donati MA; Volonte D; Galbiati F; Cordone G; Bricarelli FD; Lisanti MP; Zara F
Nat Genet; 1998 Apr; 18(4):365-8. PubMed ID: 9537420
[TBL] [Abstract][Full Text] [Related]
6. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype.
Galbiati F; Volonte D; Chu JB; Li M; Fine SW; Fu M; Bermudez J; Pedemonte M; Weidenheim KM; Pestell RG; Minetti C; Lisanti MP
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9689-94. PubMed ID: 10931944
[TBL] [Abstract][Full Text] [Related]
7. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle.
Matsuda C; Hayashi YK; Ogawa M; Aoki M; Murayama K; Nishino I; Nonaka I; Arahata K; Brown RH
Hum Mol Genet; 2001 Aug; 10(17):1761-6. PubMed ID: 11532985
[TBL] [Abstract][Full Text] [Related]
8. Caveolin-3 and nitric oxide synthase I in healthy and diseased skeletal muscle.
Gossrau R
Acta Histochem; 1998 Feb; 100(1):99-112. PubMed ID: 9542584
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy.
Herrmann R; Straub V; Blank M; Kutzick C; Franke N; Jacob EN; Lenard HG; Kröger S; Voit T
Hum Mol Genet; 2000 Sep; 9(15):2335-40. PubMed ID: 11001938
[TBL] [Abstract][Full Text] [Related]
10. Freeze-fracture studies of muscle caveolae in human muscular dystrophy.
Bonilla E; Fischbeck K; Schotland DL
Am J Pathol; 1981 Aug; 104(2):167-73. PubMed ID: 7258302
[TBL] [Abstract][Full Text] [Related]
11. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy.
Hayashi YK; Matsuda C; Ogawa M; Goto K; Tominaga K; Mitsuhashi S; Park YE; Nonaka I; Hino-Fukuyo N; Haginoya K; Sugano H; Nishino I
J Clin Invest; 2009 Sep; 119(9):2623-33. PubMed ID: 19726876
[TBL] [Abstract][Full Text] [Related]
12. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins.
Song KS; Scherer PE; Tang Z; Okamoto T; Li S; Chafel M; Chu C; Kohtz DS; Lisanti MP
J Biol Chem; 1996 Jun; 271(25):15160-5. PubMed ID: 8663016
[TBL] [Abstract][Full Text] [Related]
13. Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype.
Aravamudan B; Volonte D; Ramani R; Gursoy E; Lisanti MP; London B; Galbiati F
Hum Mol Genet; 2003 Nov; 12(21):2777-88. PubMed ID: 12966035
[TBL] [Abstract][Full Text] [Related]
14. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
Smythe GM; Eby JC; Disatnik MH; Rando TA
J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
[TBL] [Abstract][Full Text] [Related]
15. Altered alpha1-syntrophin expression in myofibers with Duchenne and Fukuyama muscular dystrophies.
Wakayama Y; Inoue M; Kojima H; Jimi T; Yamashita S; Kumagai T; Shibuya S; Hara H; Oniki H
Histol Histopathol; 2006 Jan; 21(1):23-34. PubMed ID: 16267784
[TBL] [Abstract][Full Text] [Related]
16. Membrane structure of caveolae and isolated caveolin-rich vesicles.
Westermann M; Leutbecher H; Meyer HW
Histochem Cell Biol; 1999 Jan; 111(1):71-81. PubMed ID: 9930886
[TBL] [Abstract][Full Text] [Related]
17. Variable reduction of caveolin-3 in patients with LGMD2B/MM.
Walter MC; Braun C; Vorgerd M; Poppe M; Thirion C; Schmidt C; Schreiber H; Knirsch UI; Brummer D; Müller-Felber W; Pongratz D; Müller-Höcker J; Huebner A; Lochmüller H
J Neurol; 2003 Dec; 250(12):1431-8. PubMed ID: 14673575
[TBL] [Abstract][Full Text] [Related]
18. Increased caveolin-3 levels in mdx mouse muscles.
Vaghy PL; Fang J; Wu W; Vaghy LP
FEBS Lett; 1998 Jul; 431(1):125-7. PubMed ID: 9684879
[TBL] [Abstract][Full Text] [Related]
19. Caveolin-3 is not an integral component of the dystrophin glycoprotein complex.
Crosbie RH; Yamada H; Venzke DP; Lisanti MP; Campbell KP
FEBS Lett; 1998 May; 427(2):279-82. PubMed ID: 9607328
[TBL] [Abstract][Full Text] [Related]
20. Freeze-fracture study of muscle plasma membrane in obligate carriers of Duchenne muscular dystrophy.
Bonilla E; Fischbeck KH; Schotland DL
Neurology; 1983 Oct; 33(10):1346-7. PubMed ID: 6684233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
